Healthcare Triage: Biologic Drugs and Biosimilars

In a previous video we compared brand name and generic drugs.  But we kind of left out a major player in the world of medicines; biologic drugs. These complicated little guys probably deserve a video all to themselves.  Call them what you will -biologics, biotherapeutic medicines, or biopharmaceuticals- they’re topic of this week’s HealthCare triage.

For those of you who want to read more:

@aaronecarroll

P.S. Thanks to Rachel Hoffman, Healthcare Triage intern, for help with this episode!!!

Aaron Carroll

Aaron E. Carroll, MD, MS is co-Editor-in-Chief of The Incidental Economist. He is President & CEO of AcademyHealth. A nationally recognized thought leader, science communicator, pediatrician, and health services researcher, he is a passionate advocate for the creation and use of evidence to improve health and health care for all. In addition to contributing regularly to The New York Times and the Atlantic, he is the author of four books, most recently The Bad Food Bible.

Hidden information below

Aaron Carroll

Aaron E. Carroll, MD, MS is co-Editor-in-Chief of The Incidental Economist. He is President & CEO of AcademyHealth. A nationally recognized thought leader, science communicator, pediatrician, and health services researcher, he is a passionate advocate for the creation and use of evidence to improve health and health care for all. In addition to contributing regularly to The New York Times and the Atlantic, he is the author of four books, most recently The Bad Food Bible.

The Incidental Economist

the health services research blog

WordPress Management: BKJ Productions
Editors In Chief
Content Manager

Work posted here under copyright © of the authors • Details on the Site Policies page

Subscribe

Email Address*